12 completed, 1 unknown. 5 Phase 3, 5 Phase 4, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 5 |
| Phase 4 | 5 | Completed 4, Unknown 1 |
| Phase 1 | 3 | Completed 3 |
Follow Teneligliptin: new trials by email Literature Review of Teneligliptin trials Research Report on Teneligliptin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers HD-P023, Teneligliptin, Empagliflozin High - Healthy Volunteers | Phase 1 | Completed | Handok Inc. | 40 | 2025-03-26 | 2025-07-31 |
| Pharmacokinetics of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers HD-P023, Teneligliptin, Empagliflozin - Healthy Volunteers | Phase 1 | Completed | Handok Inc. | 40 | 2024-05-10 | 2025-02-04 |
| Pharmacokinetic Drug Interaction Between Teneligliptin and Empagliflozin Teneligliptin, Empagliflozin, Teneligliptin and Empagliflozin - Type 2 Diabetes Mellitus | Phase 1 | Completed | Handok Inc. | 32 | 2020-09-15 | 2021-11-15 |
| A Randomized, Placebo-controlled Clinical Trial of Teneligliptin as Quadruple Oral Combination Therapy for Type 2 DM After Failure of an Oral Triple Anti-diabetic Regimen teneligliptin, Placebo - Type 2 Diabetes Mellitus | Phase 4 | Completed | Yonsei University | 100 | 2020-07-08 | 2021-06-09 |
| Tenelia Elderly CGMS Study(TEDDY) Teneligliptin, Placebo - Type 2 Diabetes Mellitus | Phase 4 | Completed | Handok Inc. | 65 | 2018-04-03 | 2022-06-30 |
| Teneligliptin Versus Linagliptin in Diabetes Mellitus Type Two Patients Teneligliptin, Linagliptin - Type2 Diabetes Mellitus | Phase 4 | Completed | Handok Inc. | 168 | 2017-01-01 | 2019-02-22 |
| Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study) Teneligliptin, Sitagliptin - Type 2 Diabetes Mellitus | Phase 4 | Completed | Handok Inc. | 39 | 2015-08-27 | 2025-01-27 |
| Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction With Type 2 Diabetes Mellitus Study Teneligliptin - Diabetes Mellitus, Type 2 | Phase 4 | Unknown | National Cerebral and Cardiovascular Center, Japan | 936 | 2015-06-01 | 2018-08-22 |
| Tenelia Triple Combination Study Teneligliptin - Type 2 Diabetes Mellitus | Phase 3 | Completed | Handok Inc. | 201 | 2015-04-01 | 2018-05-02 |
| Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin) Teneligliptin, Canagliflozin, Placebo - Type 2 Diabetes Mellitus | Phase 3 | Completed | Tanabe Pharma Corporation | 138 | 2015-01-01 | 2026-01-07 |
| Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin) Canagliflozin, Teneligliptin, Placebo - Type 2 Diabetes Mellitus | Phase 3 | Completed | Tanabe Pharma Corporation | 154 | 2015-01-01 | 2026-01-07 |
| Long-term Safety Study of MP-513 in Patients With Type 2 Diabetes teneligliptin, glinide, biguanide - Type 2 Diabetes Mellitus | Phase 3 | Completed | Tanabe Pharma Corporation | 462 | 2011-02-01 | 2026-01-02 |
| Long-term Safety Study of MP-513 as Monotherapy or in Combination With Sulfonylurea in Japanese Type 2 Diabetic Patients Teneligliptin, Teneligliptin + Sulfonylurea - Type 2 Diabetes Mellitus | Phase 3 | Completed | Tanabe Pharma Corporation | 240 | 2009-08-01 | 2026-01-05 |
Diabetes Mellitus, Type 2 (10) · Insulin Resistance (1)
Handok Inc. (7) · Tanabe Pharma Corporation (4) · National Cerebral and Cardiovascular Center, Japan (1) · Yonsei University (1)
South Korea (8) · Japan (5)
Kazuoki Kondo, MD (3) · Takashi Kadowaki, Professor (2) · JH Kim (1) · Kazuoki Kondo, M.D. (1) · Sin Gon Kim, MD, Ph.D (1) · Takashi Kadowaki, M.D. (1) · Takashi Kadowaki, MD (1)